Water → HCID 68000370, compound
Reaction equation
[CH2:1]([C@@:4]1(C)[CH2:9][C@H:8]([C:10]2[CH:15]=[C:14]([F:16])[CH:13]=[C:12]([Cl:17])[CH:11]=2)[C@@H:7]([C:18]2[CH:23]=[CH:22][C:21]([Cl:24])=[CH:20][CH:19]=2)[N:6]([C@@H:25]([CH2:33][CH3:34])[CH2:26][NH:27][S:28]([CH2:31][CH3:32])(=[O:30])=[O:29])[C:5]1=[O:35])C=C.CC#N.O.I([O-])(=O)(=O)=O.[Na+].CC[O:49][C:50]([CH3:52])=[O:51]>O.[Ru](Cl)(Cl)Cl>[Cl:17][C:12]1[CH:11]=[C:10]([C@@H:8]2[C@@H:7]([C:18]3[CH:19]=[CH:20][C:21]([Cl:24])=[CH:22][CH:23]=3)[N:6]([C@@H:25]([CH2:33][CH3:34])[CH2:26][NH:27][S:28]([CH2:31][CH3:32])(=[O:30])=[O:29])[C:5](=[O:35])[C@:4]([CH2:52][C:50]([OH:49])=[O:51])([CH3:1])[CH2:9]2)[CH:15]=[C:14]([F:16])[CH:13]=1Participants
Procedure
To a solution of N-((S)-2-((3S,5R,6S)-3-allyl-5-(3-chloro-5-fluorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-1-yl)butyl)ethanesulfonamide (Example 393, Step C, 120 mg, 0.216 mmol) in EtOAc:MeCN:water (1.450 mL) (2/2/3) at rt was added sodium periodate (185 mg, 0.864 mmol) slowly. Then ruthenium chloride hydrate (1.071 mg, 4.75 μmol) was added. The mixture was stirred vigourously at rt for 2 h. Then the mixture was filtered and the solid was washed with EtOAc. The filtrate was extracted with EtOAc 2×. The combined organic layers were dried over Na2SO4, filtered and the filtrate was concentrated under reduced pressure. The residue was purified by reverse phase preparatory HPLC (column: Gemini™ Prep C18 5 um column; Phenomenex, Torrance, Calif.; eluent: 0 to 100% MeCN +0.1% TFA in water +0.1% TFA, over 20 minutes) to give the title compound.
Workup
- filtrationThen the mixture was filtered
- washthe solid was washed with EtOAc
- extractionThe filtrate was extracted with EtOAc 2×
- dry with materialThe combined organic layers were dried over Na2SO4
- filtrationfiltered
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residue was purified by reverse phase preparatory HPLC (column: Gemini™ Prep C18 5 um column; Phenomenex, Torrance, Calif.; eluent: 0 to 100% MeCN +0.1% TFA in water +0.1% TFA, over 20 minutes)
Sources & evidence
- ORD record
- ord-1b15a0c6cef84856a398209804a0981c
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09296736B2
Reaction notes
Loading…